Medicine Overview of Ikgdar-500mg Tablet
Uses of Ikgdar-500mg Tablet
Ikgdar 500mg injection and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC).
Ikgdar 500mg injection is also used with methotrexate (Otrexup, Rasuvo, Xatmep, others) for the treatment rheumatoid arthritis symptoms in adults that have been already treated with a some type of regimen knowns as tumor necrosis factor (TNF) inhibitor.
Ikgdar 500mg injection is a type in a classification of drugs called monoclonal antibodies.
Ikgdar 500mg injection is used to killing cancer cells to treat NHL , CLL, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis by stopping the activity of the part of the immune system which can damage the joints, veins, and other blood vessels and cause damage to organs (heart and lungs).
Side effects of Ikgdar-500mg Tablet
Common effects: fever and chills (flu lik symptoms)
Less common side effects:
Weakness; nausea ; headache; cough ; dyspnea ; pharyngitis
How to use Ikgdar-500mg Tablet
Ikgdar injection is recommended to administer only through intravenous infusion not by IV push or bolus.
PREMEDICATE BEFORE EACH INFUSION
First infusion: initially rate of 50 mg/hr is given , in not showing infusion toxicity, rate rised upto 50 mg/hr increments at intervals of 30 min and max of 400 mg/hr.
Successive infusion: start at rate of 100 mg/hr, in not showing infusion toxicity, rate raised upto 100 mg/hr increments at intervals of 30 min and max of 400 mg/hr.
Premedication with corticosteroids must be considered, if Ikgdar injection combination with CHOP chemotherapy is not given.
LOW GRADE OR FOLLICULAR NON-HODGKINS LYMPHOMA:
Dose is 375 mg/m2 as an IV infusion.
Relapsed treatment : once weeks for 4 or 8 doses administrated.
Retreatment for relapsed : once weekly for 4 doses administrated.
Previously untreated : administer on day 1 of each cycle of chemotherapy, upto 8 doses. In complete or partial response of patient, start with 8 weeks for maintenance following rituximab in combination with chemotherapy completed then administer 8 weeks for 12 dose as a single agent.
Non – progression ( following CVP chemotherapy completion 6 – 8 cycles): once weekly for 4 dose at intervals of 6 months and max of 16 dose.
Diffuse large B- cell NHL : on day 1 each cycle of chemotherapy upto 8 infusions.
CHRONIC LYMPHOCYTIC LEUKEMIA
Before starting of FC chemotherapy, dose recommended is 375 mg/m2 followed 500 mg/m2 on day 1 of 2-6 cycles every 28 days.
COMPONENT OF ZEVALIN FOR TREATMENT OF NHL:
Ikgdar infusion about 250 mg/m2 within 4 hours prior to the administration of Indium-111-(In-111-) Zevalin and Yttrium-90- (Y-90-) Zevalin.
Rituxan and In-111-Zevalin 7–9 days before to Rituxan and Y-90- Zevalin administrated.
Ikgdar injection is administer with methotrexate combination
Ikgdar injection administrating as two dose of 100mg IV infusion 2 weeks separated.
When glucocorticoids administered as methylprednisolone 100mg IV
Successive course based on clinical evaluation must administer every 24 weeks,but not early than every 16 weeks.
GRANULOMATOSIS POLYANGITIS AND MICROSCOPIC POLYANGITIS
Dose of 375 mg/m2 IV infusion weekly once for 4 weeks.
When Glucocorticoids treat with methylprednisolone by dose of 1000 mg IV/ day for 1- 3 days and purse by oral prednisone 1 mg/kg/day are recommended for the treatment of symptoms of serious vasculitis . This drug should intiate within 14 days before or with the starting of Ikgdar injection and may continue during and after the 4 week course with treatment of Ikgdar injection.
Safety and not established for subsequent infusion.
Take an Ikgdar injection amount and diluted to final concentration of 1 mg/ml upto 4 mg/ml as infusion (containing either 0.9% Nacl or 5% dextrose in water). Invert gently the bag and mix the solution. Dispose unused drug left in vial.
OVERDOSAGE: If overdosage occurs seek immediately to the emergency department or poison control help line.
Please consult the doctor for further clarification.
How to Ikgdar-500mg Tablet works:
Ikgdar 500mg injection is a type of class called as monoclonal antibody. Its an new type of "targeted" cancer treatment andan integral part of the body's immune system. The body naturallybuild antibodies in associated to an antigen that has entered the body and attach to the antigen for destruction by the immune system.
Specific cells only targeted by monoclonal antibiotics, they may cause less toxicity to healthy cell and it is usually treatment recommended only for cancers in which antigens (and the respective antibodies) have been already identified.
Ikgdar 500mg injection works by linking to the CD20 antigen on normal and malignant B-cells. There by body's natural immune security are initiated to attack and kill the marked B-cells. Stem cells i.e young cells in the bone marrow which will grow into the various cell types and do not have the CD20 antigen. CD20 antigen allows healthy B-cells to reproduce after treatment.
Absorption: Not available
Distribution: no plasma protein binding and volume of distribution is 3.1 L
Metabolism: Ikgdar 500mg injection metabolized by human antimurine antibody production.
Elimination : not available
Terminal elimination of half life of NHL is 22 days and for RA is 18.0 days, GPA and microscopic polyangitis is 23 days
In Depth Information on Ikgdar-500mg Tablet:
Expert Advice for Ikgdar-500mg Tablets
- Allgeric condition against Ikgdar 500mg injection or any other medication inform your doctor.
- Regarding your past medical drug used which include in prescription, non-prescription, vitamins & supplements , nutritional products just inform the doctor.
- While using Ikgdar 500mg injection do not take any vaccination or immunization without taking advice from doctors.
- Avoid use of Ikgdar 500mg injection if you are pregnant. It will harm the baby unborn, while using Ikgdar injection use correct birth control to prevent pregnancy and for at least 2 weeks after your treatment ends. Ikgdar injection may affect the ability to have children in women. Inform your doctor if you planning to pregnant.
- It is unknown whether Ikgdar 500mg injection passes into breast milk , avoid breast-feed while on Ikgdar injection treatment.
- Discard the unused drug by asking the advice from doctor or pharmacist.
Special Warnings of Ikgdar-500mg Tablets
Ikgdar 500mg injection interaction with alcohol is unknown. Please consult with the doctor.
Category C : Animal studies reproduction shown an adverse effect on the fetus. There is no sufficient and well controlled studies in humans, using in pregnant women benefits by warrant use of the drug.
Ikgdar 500mg injection excreted into human milk is unknown. Because the drug is a large protein molecule, no information is available. Women should not breast feed during Ikgdar injection treatment and 12 months following last dose.
The action of Ikgdar 500mg injection while driving is unknown whether it will affects the driving abilty. If you experienced any symptoms of side effects then avoid driving until you feeling well.
Ikgdar 500mg injection using in patients with kidney disease is probably safe. Ikgdar injection has limited data on dose adjustment may not be necessary in these patients. Please consult the doctor.
Ikgdar 500mg is not prescribed in patients with the active hepatic problem or patients having viral hepatitis as it infection can reactivate. Limited data available on patients with liver disease. Please consult the doctor.
If you missed a dose take it as soon as possible, if time reach for next dose, then skip missed dose and continue and continue the regular schedule. Do not take extra or 2 dose at a same time.
Amazing Review by Millionpharma
Write Your Own Review
Brand Name : <--------------------> Ikgdar-500mg
Category : <--------------------> Anti-Cancer Drugs
Sub Category :<--------------------> Rituximab
Company Name :<--------------------> Emcure pharmaceuticals Ltd
Ingeridents(Generic Name) :<--------------------> Rituximab
Dosage Form :<--------------------> 1 vial
Package :<--------------------> 1x1
Strength :<--------------------> 500mg